Metastasis-associated lung adenocarcinoma transcript 1 (MALAT-1), a long non-coding RNA, has been documented to be a new prognostic marker and gene regulator in several types of cancer, but its potential involvement in acute myeloid leukemia (AML) remains unclear. This study investigated the expression and functional role of MALAT-1 in AML. MALAT-1 expression was assessed by real-time quantitative PCR. After lentiviral-mediated MALAT-1 knockdown, the proliferation of AML cells was determined by CCK-8 and colony formation assays. Cell cycle progression and apoptosis were evaluated by flow cytometry and the expression of caspase-3, -8 and -9 was assessed by western blot analysis. We found that MALAT-1 expression in patients with acute monocytic leukemia (M5) was significantly increased when compared with that of healthy controls, and the overall survival of M5 patients with high MALAT-1 expression was markedly reduced when compared with the overall survival of patients with low MALAT-1 expression. The analysis of cellular experiments showed that MALAT-1 silencing decreased the proliferation of M5 cells (U-937 and THP-1), inhibited cell cycle progression and increased apoptosis. Taken together, these findings suggest that high MALAT-1 expression is closely associated with poor prognosis in M5 patients and may play a role in leukemia cell proliferation and apoptosis, and may serve as a promising theranostic marker.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549035PMC
http://dx.doi.org/10.3892/or.2017.5802DOI Listing

Publication Analysis

Top Keywords

malat-1 expression
20
malat-1
10
long non-coding
8
non-coding rna
8
poor prognosis
8
cell proliferation
8
proliferation apoptosis
8
acute monocytic
8
monocytic leukemia
8
cell cycle
8

Similar Publications

Background: Numerous studies have demonstrated the significance of long noncoding RNA (lncRNA) in the development of cancer metastasis. The expression levels of many lncRNAs are elevated in metastatic lung cancer patients compared to non-metastatic lung cancer patients.

Objectives: The primary objective of the study was to investigate the association between the expression levels of three lncRNAs (MALAT1, HOTAIR, and AFAP1-AS1) and lymph node metastasis (LNM) of lung cancer.

View Article and Find Full Text PDF

Exploring New and Promising Genetic Biomarkers for Evaluating Traumatic Brain Injuries: A Case-Control Study.

Neurochem Res

December 2024

Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Cairo University, Kasr Alainy Street, Cairo, 11562, Egypt.

Article Synopsis
  • Traumatic brain injury (TBI) affects around 50 million people yearly, highlighting the need for effective blood-based biomarkers for diagnosis and prognosis.
  • Researchers tested four biomarkers (AKT3, GSK-3β, hsa-miR-16-5p, and MALAT-1) in 30 TBI patients and 10 healthy controls, using blood samples over 30 days.
  • The study found AKT3, hsa-miR-16-5p, and GSK-3β to be reliable for diagnosing TBI across various severities, while MALAT-1 was particularly useful for severe cases, showing its ability to aid in prognosis for up to 30 days post-injury.
View Article and Find Full Text PDF

Recently, our research group reported an upregulated expression profile of cystathionine γ-lyase (CSE) and cystathionine β-synthase (CBS), key enzymes involved in hydrogen sulfide (HS) production, in triple-negative breast cancer (TNBC) patients. However, the regulatory mechanisms underlying such altered expression patterns are not yet fully understood. In this study, we focused on the role of the STAT3/CSE/HS axis and the potential involvement of non-coding RNAs (ncRNAs), including long and short ncRNAs, in modulating this pivotal pathway.

View Article and Find Full Text PDF

High fructose diet (HFrD) has been approved to be involved in the pathogenesis of insulin resistance. Mesenchymal stem cells have a vital role in the treatment of various diseases including metabolic disturbances. We investigated the effect of Adipose-derived mesenchymal stem cells (ADMSCs) against HFrD-induced metabolic disorders and the molecular mechanisms for this effect.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the expression of five long non-coding RNAs (HOTAIR, MALAT-1, XIST, SNHG15, and H19) in patients with diffuse large B-cell lymphoma (DLBCL) to investigate their relationship with various clinical features.
  • Results indicated that HOTAIR was significantly elevated while SNHG15 was downregulated in DLBCL patients, with both showing potential as distinguishing biomarkers between those with DLBCL and healthy individuals.
  • The findings suggest that specific lncRNAs could aid in diagnosing and staging DLBCL, as well as predicting patient outcomes, warranting further research to understand their long-term impact on survival and disease progression.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!